Jobs
View more job listings or post a job
Theravance Biopharma Post Doctoral Fellow, Clinical Pharmacology and DMPK at Theravance Biopharma
Charles River Laboratories Senior Scientist
Nektar Therapeutics Associate Director, Non Clinical PK
University of California, Davis - CAHFS-Equine Analytical Chemistry Program CONFIRMATION TECHNICIAN (Staff Research Associate III) Requisition #03022344         
University of California, Davis - CAHFS-Equine Analytical Chemistry Program LC-MS CHEMIST (Staff Research Associate III) Requisition #03022366  
Pliant Therapeutics, Inc. Sr. Scientist, DMPK
Pliant Therapeutics, Inc. Associate Scientist/Scientist Biology
Cytokinetics Research Associate II - Senior Research Associate, DMPK
Cytokinetics Research Associate III/Senior Research Associate, HTS-Discovery Biology
Cytokinetics Research Associate III/Senior Research Associate, Discovery Biology
Post a job

Workshop

Understanding and Overcoming High Clearance and Poor Bioavailability: Fundamentals, Investigations and Strategies for Drug Discovery


Speakers: Matthew Wright (Genentech), Vahid Zia (Gilead), Simon Wong (Genentech), Eugene Chen (Genentech), Jaochim Rudolph (Genentech), John Link (Gilead), Fabio Broccatelli (Genentech), Bernard Murray (Gilead)
Organizers: Matthew Wright (Genentech)
Date: 5/22/2018
Time: 8:45-17:00
Registration fee (USD): Regular: $195; Academic: $125; For unemployed or students: $30; For vendor-show rep: $35; For major-sponsor rep (incl lunch): $0;
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (2)Catalent Pharma Solutions; Worldwide Clinical Trials
Vendor show vendors registered to date: (18)Absorption Systems; ACROBiosystems; BioDuro; Celerion; ChemPartner; Cyprotex; Cytovier; Foster Delivery Science; Intertek; Pacific BioLabs; Pion Inc.; Q2 Solutions; QPS; Quotient Sciences; Sekisui XenoTech, LLC; Selvita Inc.; Seventh Wave; Simulations Plus, Inc.
Registration: http://www.PBSS.org
Registration deadline:5/21/2018  (it will close sooner if the seating cap is reached)

About the Topic

Poor exposure following oral administration is a common challenge facing discovery programs and consequently a frequent focus for DMPK scientists. Frequently, potent compounds cannot be further developed due to less-than-ideal ADME (absorption, distribution, metabolism, and excretion) properties that prevent the compounds to be available following oral administration. Beyond the discovery phase the importance of understanding and optimizing oral exposure continues in the preclinical and ultimately clinical phases of drug development. Inadequate oral exposure could be due to suboptimal physicochemical properties, or problems in absorption from the gut, or first-pass metabolism in the gut and liver, or high intrinsic clearance of the compounds.

The focus of this workshop/symposium is on: 1) to identify and learn about the issues that contribute to low oral exposure, 2) to discuss approaches that one could use to overcome those challenges, 3) to present additional methodologies that can aid in solving exposure problems and 4) to provide suggestions on how to work with partners in Medicinal Chemistry and Biological Sciences within Project Teams.

This workshop/symposium will cover the following topics:

  • Pharmacokinetic concepts – absorption, bioavailability, and clearance factors contributing to low oral exposure
  • Physiological factors that affect oral exposure
  • Physicochemical factors that influence oral exposure
  • Metabolism-based issues that give rise to poor oral exposure
  • Transporter-based issues that give rise to poor oral exposure
  • How to identify the source of problem in oral exposure – properties of the molecules or conditions of the experiment?
  • Biopharmaceutical Aspects of oral drug exposure
  • Approaches to overcome oral exposure issues, including case studies
  • Enabling Exposure of ADME Challenged compounds
  • What do Medicinal Chemists/Biologists want and how can we work with them

Workshop Agenda:

8:45 - 8:50am  PBSS Welcome M. Wright

8:50 - 9:25am  1. Pharmacokinetic Concepts (Matthew Wright)

9:25 – 10:00 am  2. Absorption of Drugs from the GI Tract (Vahid Zia)

10:00 - 10:20am  Major Sponsor Presentation Worldwide Clinical Trials

10:20 - 10:35am  Break

10:35 - 11:20pm  3. Metabolism-based issues in oral bioavailability (Simon Wong)

11:20 – 12:00 pm  4. Transporter-based issues in oral bioavailability (Eugene Chen)

12:00 - 1:00pm  Lunch

Minisymposium Agenda:

1:00 – 1:45 pm 1. Enabling Technologies to achieve oral exposure (Jaochim Rudolph)

1:45 – 2:30 pm  2. Working in non-Lipinski Space - Discovery of GS-5885 (Ledipasvir) (John Link)

2:30 - 2:45pm  Major Sponsor Presentation Vendor name TBD

2:45 - 3:00pm  Break

3:00 - 3:45pm  3. In silico applications (Fabio Broccatelli)

3:45 – 4:00 pm Break

4:00 - 4:45pm  4. Characterization and differentiation of apparently metabolically stable compounds (Bernard Murray)

4:45 - 5:00pm  Wrap-up (Matthew Wright)


2018-11-01, cGMP Compliance for Quality Control and Laboratory Operations
2018-11-16, Hybrid LC-MS for Protein therapeutics and biomarkers: Recent developments in characterization and quantification
2018-12-04, Challenges in Peptide Drug Discovery & Development: Biology, Chemistry, PK, Delivery, Regulatory and Beyond
2019-02-07, Covalent Inhibitor Drug Discovery & Development: Biology, Chemistry, PK, Safety and Case Studies (Jointly with Bay Area PKPD Network)
2019-03-07, Promising therapeutic approaches and transnational medicine from SPARK: an academic-industry collaboration to advance novel therapeutics (A Joint Symposium by PBSS and Stanford SPARK Program)
2019-03-11, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
©Pharmaceutical & BioScience Society, International; Last Modified: 10/22/2018; Visited: 45; Admin Logon
Ads (in random order)
Submit a Text Ad
($200 for 2 months)

Simulations Plus From the developers of GastroPlus™ comes PKPlus™. NCA & compartmental PK modeling for regulatory submissions. True "PlugNPlay" PK.
Nektar Therapeutics Sr. Scientist - Bioanalytical Contributes to the development, validation, and implementation of ligand-binding assays. PhD and 5 years exp.
Zef Scientific California’s premier multi-vendor LC-MS/MS engineering firm with highest level of services & rapid onsite response on all major brands & models.
Hypha Discovery Specialists in provision of drug metabolites at mg-g scale, including CYP/Non-CYP metabolites and conjugates such as glucuronides/sulfates.
Reaction Biology Corporation (RBC) RBC provides kinase & epigenetic assays and proteins for early-stage programs. Contact: kelvin.lam@reactionbiology.com
Simulations Plus ADMET Predictor™ 9 - ADMET property estimation, HTPK Simulation, SAR elucidation, and QSAR model building software.
PHARMA INVENTOR Vancouver based Canadian Custom Synthesis Services Company, Offers Inventive & Cost-Effective Chemical Synthesis Services to Life Sciences Industries.
Origin Bioanalytical Laboratory A contract research organization for bioanalytical LC-MS/MS analysis specializing in ocular tissues/fluids located Rancho Cordova, CA
Sirius Analytical Services and Automated Instruments for pKa, log P/D, solubility, dissolution. New Scissor instrument for sub-cutaneous injection site simulation.
INTERTEK PHARMACEUTICAL SERVICES Intertek, a bioanalytical CRO (drugs, biologics, proteins, ADCs, biosimilar, generics, peptide, biomarker, immunogenicity, ADA, Nab) in San Diego CA
Solid Form Solutions Ltd Solid Form Solutions Ltd CRO providing Solid State Crystallization and Analytical Testing Services to the pharma/biotech industries.
BIOTECH WEEK BOSTON - Sept. 4-7 Join us at Biotech Week Boston - Where Big Science and Bright Minds Meet. Sept. 4-7, 2018 at Hynes Convention Center.
Pharmaron Our Vision: To become the world-leading small-molecule life science R&D service company, supporting our partners from discovery to commercialization
Simulations Plus GastroPlus™ PBPK modeling workshops scheduled around the globe to train scientists on the new guidance documents from the FDA and EMA. Register today!
Simulations Plus From sketching chemical structures, all the way through regulatory filings, Simulations Plus consulting experts can help. Over 20 years of experience!
UC Davis UC Davis Liquid Chromatography/Mass Spectrometry and Confirmation Supervisor Apply Online: http://50.73.55.13/counter.php?id=139228 UC Davis i
Charles River 2nd Annual Viral Summit The 2-day summit unites industry experts in an interactive setting to share updates and discuss trends in viral safety and viral clearance.
Pharm-Olam International Pharm-Olam is a midsize CRO offering a wide range of Phase I-IV comprehensive, clinical research services to the pharma, biotech & device industries.
Pacific BioLabs Offers toxicology,microbiology,analytical and bioanalytical services with a combination of technical expertise & rigorous quality systems.
Protein Characterization Seminar hosted by Charles River Join us in San Diego on September 15, 2017 to discuss the analytical methods used to detect process residuals and determine biosimilarity.
Clinverse Inc. A global technology company solely focused on automating the financial management of clinical trials.
Avecia Pharma Services Nitto Avecia Pharma provides GMP contract development and parenteral manufacturing services to the pharma/biotech industries. Visit our Irvine labs!
S-Matrix Fusion QbD® Software – Analytical Method Development & Validation, Formulation & Process R&D. Works with ChemStation, Chromeleon, and Empower.
MicroConstants MicroConstants is a GLP-compliant Contract Research Organization focused on performing regulated bioanalysis, drug metabolism and PK analysis.
Nuventra Pharma Sciences With a background in clinical pharmacology and PK/PD, Nuventra enables our clients to make better strategic decisions.
Submit a Text Ad